Moy Brian T, Birk John W
Department of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, Farmington, CT, USA.
J Clin Transl Hepatol. 2019 Mar 28;7(1):61-71. doi: 10.14218/JCTH.2018.00028. Epub 2018 Dec 3.
Orthotopic liver transplantation is the definitive treatment for end-stage liver disease and hepatocellular carcinomas. Biliary complications are the most common complications seen after transplantation, with an incidence of 10-25%. These complications are seen both in deceased donor liver transplant and living donor liver transplant. Endoscopic treatment of biliary complications with endoscopic retrograde cholangiopancreatography (commonly known as ERCP) has become a mainstay in the management post-transplantation. The success rate has reached 80% in an experienced endoscopist's hands. If unsuccessful with ERCP, percutaneous transhepatic cholangiography can be an alternative therapy. Early recognition and treatment has been shown to improve morbidity and mortality in post-liver transplant patients. The focus of this review will be a learned discussion on the types, diagnosis, and treatment of biliary complications post-orthotopic liver transplantation.
原位肝移植是终末期肝病和肝细胞癌的确定性治疗方法。胆道并发症是移植后最常见的并发症,发生率为10%-25%。这些并发症在尸体供肝肝移植和活体供肝肝移植中均可见。通过内镜逆行胰胆管造影术(通常称为ERCP)对胆道并发症进行内镜治疗已成为移植后管理的主要手段。在经验丰富的内镜医师手中,成功率已达到80%。如果ERCP治疗失败,经皮经肝胆管造影术可以作为替代治疗方法。早期识别和治疗已被证明可改善肝移植术后患者的发病率和死亡率。本综述的重点将是关于原位肝移植后胆道并发症的类型、诊断和治疗的学术讨论。